These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11276286)

  • 41. Splenomegaly in primary antiphospholipid syndrome without accompanying portal hypertension or comorbidity.
    Cikrikcioglu MA; Hursitoglu M; Erkal H; Inan B; Ozturk T; Cakirca M; Canpolat F; Erkal S; Bahtiyar I; Cordan I; Tukek T
    Pathophysiol Haemost Thromb; 2010; 37(2-4):104-9. PubMed ID: 21555872
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antiphospholipid-mediated thrombosis: interplay between type of antibodies and localisation of lung, and cardiovascular incidences in primary antiphospholipid syndrome.
    Stojanovich L; Djokovic A; Kontic M
    Clin Exp Rheumatol; 2015; 33(4):531-6. PubMed ID: 26088955
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pulmonary hypertension and the antiphospholipid syndrome.
    Koike T; Tsutsumi A
    Intern Med; 1995 Oct; 34(10):938. PubMed ID: 8563092
    [No Abstract]   [Full Text] [Related]  

  • 44. Pulmonary hypertension in antiphospholipid syndrome.
    Zuily S; Wahl D
    Curr Rheumatol Rep; 2015 Jan; 17(1):478. PubMed ID: 25604574
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnosis of portopulmonary hypertension in candidates for liver transplantation: a prospective study.
    Colle IO; Moreau R; Godinho E; Belghiti J; Ettori F; Cohen-Solal A; Mal H; Bernuau J; Marty J; Lebrec D; Valla D; Durand F
    Hepatology; 2003 Feb; 37(2):401-9. PubMed ID: 12540791
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pulmonary hypertension in liver transplant.
    Ayoub T
    Curr Opin Organ Transplant; 2011 Jun; 16(3):331-7. PubMed ID: 21519260
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The antiphospholipid syndrome: its cardiological aspects].
    Nasonov EL; Karpov IuA; Alekberova ZS; Vil'chinskaia MIu; Fomicheva OA
    Ter Arkh; 1993; 65(11):80-6. PubMed ID: 8108810
    [No Abstract]   [Full Text] [Related]  

  • 48. Successful treatment of severe portopulmonary hypertension after liver transplantation by bosentan.
    Clift PF; Townend JN; Bramhall S; Isaac JL
    Transplantation; 2004 Jun; 77(11):1774-5. PubMed ID: 15201683
    [No Abstract]   [Full Text] [Related]  

  • 49. [Severe pulmonary arterial hypertension and primary antiphospholipid antibodies syndrome].
    Cafagna D; Volpe C; Cresi RM; Scardi S
    G Ital Cardiol; 1993 Oct; 23(10):1005-8. PubMed ID: 8174854
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatopulmonary syndrome and portopulmonary hypertension: recent knowledge in pathogenesis and overview of clinical assessment.
    Raevens S; Geerts A; Van Steenkiste C; Verhelst X; Van Vlierberghe H; Colle I
    Liver Int; 2015 Jun; 35(6):1646-60. PubMed ID: 25627425
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recurrent portopulmonary hypertension after liver transplantation: management with epoprostenol and resolution after retransplantation.
    Kett DH; Acosta RC; Campos MA; Rodriguez MJ; Quartin AA; Schein RM
    Liver Transpl; 2001 Jul; 7(7):645-8. PubMed ID: 11460234
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Pulmonary hypertension complicating portal hypertension: portopulmonary hypertension].
    Katsuta Y; Zhang XJ; Aramaki T
    Nihon Rinsho; 2001 Jun; 59(6):1186-92. PubMed ID: 11411134
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Portopulmonary hypertension in childhood presenting as sudden death.
    Weber MA; Ashworth MT; Sebire NJ
    Pediatr Dev Pathol; 2006; 9(1):65-71. PubMed ID: 16808632
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Calcium channel blockers in primary pulmonary hypertension.
    Rubin LJ
    Chest; 1985 Oct; 88(4 Suppl):257S-260S. PubMed ID: 4042732
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Survival in portopulmonary hypertension: Outcomes of the United Kingdom National Pulmonary Arterial Hypertension Registry.
    Sithamparanathan S; Nair A; Thirugnanasothy L; Coghlan JG; Condliffe R; Dimopoulos K; Elliot CA; Fisher AJ; Gaine S; Gibbs JSR; Gatzoulis MA; E Handler C; Howard LS; Johnson M; Kiely DG; Lordan JL; Peacock AJ; Pepke-Zaba J; Schreiber BE; Sheares KKK; Wort SJ; Corris PA;
    J Heart Lung Transplant; 2017 Jul; 36(7):770-779. PubMed ID: 28190786
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chronic Thromboembolic Pulmonary Hypertension and Antiphospholipid Syndrome with Immune Thrombocytopenia: A Case Report.
    Skride A; Sablinskis M; Sablinskis K; Lejniece S; Lejnieks A; Klepetko W; Lang IM
    Am J Case Rep; 2018 Oct; 19():1245-1248. PubMed ID: 30337514
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Pulmonary complications of hepatic cirrhosis: portopulmonary hypertension and hepatopulmonary syndrome. The paradox of pulmonary vasoconstriction and vasodilation].
    Chávez-Tapia NC; Uribe M; López E
    Gac Med Mex; 2007; 143(4):333-9. PubMed ID: 17969842
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Portopulmonary hypertension and right heart failure in patients with cirrhosis.
    Ramsay M
    Curr Opin Anaesthesiol; 2010 Apr; 23(2):145-50. PubMed ID: 20124995
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Portopulmonary hypertension: imatinib as a novel treatment and the Emory experience with this condition.
    Tapper EB; Knowles D; Heffron T; Lawrence EC; Csete M
    Transplant Proc; 2009 Jun; 41(5):1969-71. PubMed ID: 19545770
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Effect of calcium channel antagonists in primary pulmonary hypertension in association with human immunodeficiency virus infection].
    Bragulat E; García F; Fernández F; Ballester E; Villalta J; Grau JM
    An Med Interna; 1998 Feb; 15(2):114. PubMed ID: 9542214
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.